Is Hippocampal Volumetry Really All That Matters?

References

1. 1.↵
   2. Tanpitukpongse TP,
   3. Mazurowski MA,
   4. Ikhena J, et al

   ; Alzheimer's Disease Neuroimaging Initiative. Predictive utility of marketed volumetric software tools in subjects at risk for Alzheimer disease: do regions outside the hippocampus matter? AJNR Am J Neuroradiol 2017;38:546–52 doi:10.3174/ajnr.A5061 pmid:28057634

   Abstract/FREE Full Text
2. 2.↵
   2. Dickerson BC,
   3. Bakkour A,
   4. Salat DH, et al

   . The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 2009;19:497–510 doi:10.1093/cercor/bhn113 pmid:18632739

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Dickerson BC,
   3. Stoub TR,
   4. Shah RC, et al

   . Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 2011;76:1395–402 doi:10.1212/WNL.0b013e3182166e96 pmid:21490323

   Abstract/FREE Full Text
4. 4.↵
   2. Hutton C,
   3. Draganski B,
   4. Ashburner J, et al

   . A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging. Neuroimage 2009;48:371–80 doi:10.1016/j.neuroimage.2009.06.043 pmid:19559801

   CrossRefPubMed
5. 5.↵
   2. Haller S,
   3. Barkhof F

   . Interaction of vascular damage and Alzheimer dementia: focal damage and disconnection. Radiology 2017;282:311–13 doi:10.1148/radiol.2016161564 pmid:28099102

   CrossRefPubMed
6. 6.↵
   2. Haller S,
   3. Falkovskiy P,
   4. Meuli R, et al

   . Basic MR sequence parameters systematically bias automated brain volume estimation. Neuroradiology 2016;58:1153–60 doi:10.1007/s00234-016-1737-3 pmid:27623782

   CrossRefPubMed
7. 7.↵
   2. Frankó E,
   3. Joly O

   , Alzheimer's Disease Neuroimaging Initiative. Evaluating Alzheimer's disease progression using rate of regional hippocampal atrophy. PLoS One 2013;8:e71354 doi:10.1371/journal.pone.0071354 pmid:23951142

   CrossRefPubMed
8. 8.↵
   2. Haller S,
   3. Nguyen D,
   4. Rodriguez C, et al

   . Individual prediction of cognitive decline in mild cognitive impairment using support vector machine-based analysis of diffusion tensor imaging data. J Alzheimers Dis 2010;22:315–27 doi:10.3233/JAD-2010-100840 pmid:20847435

   CrossRefPubMedWeb of Science
9. 9.↵
   2. O'Dwyer L,
   3. Lamberton F,
   4. Bokde AL, et al

   . Using support vector machines with multiple indices of diffusion for automated classification of mild cognitive impairment. PLoS One 2012;7:e32441 doi:10.1371/journal.pone.0032441 pmid:22384251

   CrossRefPubMed
10. 10.↵
    2. Xekardaki A,
    3. Rodriguez C,
    4. Montandon ML, et al

    . Arterial spin labeling may contribute to the prediction of cognitive deterioration in healthy elderly individuals. Radiology 2015;274:490–99 doi:10.1148/radiol.14140680 pmid:25291458

    CrossRefPubMed
11. 11.↵
    2. Binnewijzend MA,
    3. Kuijer JP,
    4. Benedictus MR, et al

    . Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology 2013;267:221–30 doi:10.1148/radiol.12120928 pmid:23238159

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Collij LE,
    3. Heeman F,
    4. Kuijer JP, et al

    . Application of machine learning to arterial spin labeling in mild cognitive impairment and Alzheimer disease. Radiology 2016;281:865–75 doi:10.1148/radiol.2016152703 pmid:27383395

    CrossRefPubMed
13. 13.↵
    2. Haller S,
    3. Lovblad KO,
    4. Giannakopoulos P, et al

    . Multivariate pattern recognition for diagnosis and prognosis in clinical neuroimaging: state of the art, current challenges and future trends. Brain Topogr 2014;27:329–37 doi:10.1007/s10548-014-0360-z pmid:24676572

    CrossRefPubMed
14. 14.↵
    2. Haller S,
    3. Fällmar D,
    4. Larsson EM

    . Susceptibility weighted imaging in dementia with Lewy bodies: will it resolve the blind spot of MRI? Neuroradiology 2016;58:217–18 doi:10.1007/s00234-015-1605-6 pmid:26458890

    CrossRefPubMed
15. 15.↵
    2. Kamagata K,
    3. Nakatsuka T,
    4. Sakakibara R, et al

    . Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study. Neuroradiology 2017;59:89–98 doi:10.1007/s00234-016-1773-z pmid:28035426

    CrossRefPubMed